Novo and Hims End Dispute to Partner on Obesity Drugs

Novo Nordisk will sell weight-loss drugs on the Hims & Hers platform to end a legal battle. A formal partnership announcement is expected this coming Monday.

Xurve View
Insights:

The Danish pharmaceutical company Novo Nordisk A/S and the digital health provider Hims & Hers Health, Inc. have reportedly resolved their legal dispute and entered into a partnership to distribute weight-loss treatments. This agreement brings an end to a conflict that escalated into a lawsuit last month, according to a Bloomberg News report published on Friday.

The official logo of Novo Nordisk is seen at its corporate facility in Bagsvaerd, Copenhagen, Denmark, dated February 4, 2026. Photo by REUTERS/Tom Little